Muccio VE
5  results:
Search for persons X
?
1

Phase 1/2 study of weekly carfilzomib, cyclophosphamide, de..:

Bringhen, S ; D'Agostino, M ; De Paoli, L...
https://pure.eur.nl/en/publications/19d66baf-5818-47cb-8ccd-f400717cc78f.  , 2018
 
?
2

Phase 1/2 study of weekly carfilzomib, cyclophosphamide, de..:

Bringhen, S ; D'Agostino, M ; De Paoli, L...
Bringhen , S , D'Agostino , M , De Paoli , L , Montefusco , V , Liberati , AM , Galieni , P , Grammatico , S , Muccio , VE , Esma , F , De Angelis , C , Musto , P , Ballanti , S , Offidani , M , Petrucci , MT , Gaidano , G , Corradini , P , Palumbo , A , Sonneveld , P & Boccadoro , M 2018 , ' Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma ' , Leukemia , vol. 32 , no. 4 , pp. 979-985 . https://doi.org/10.1038/leu.2017.327.  , 2018
 
?
3

Relevance of sample preparation for flow cytometry:

Muccio VE ; Gilestro M ; SARACI, ENI...
info:eu-repo/semantics/altIdentifier/pmid/28984084.  , 2018
 
?
4

Minimal residual disease after transplantation or lenalidom..:

Oliva, S ; Gambella, M ; Gilestro, M...
info:eu-repo/semantics/altIdentifier/wos/WOS:000393289000044.  , 2017
 
1-5